Corbus Pharmaceuticals Holdings, Inc. (CRBP): Price and Financial Metrics

Corbus Pharmaceuticals Holdings, Inc. (CRBP): $52.89

1.64 (+3.20%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add CRBP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#142 of 356

in industry

CRBP Price/Volume Stats

Current price $52.89 52-week high $55.41
Prev. close $51.25 52-week low $3.03
Day low $50.79 Volume 301,526
Day high $54.38 Avg. volume 616,164
50-day MA $41.84 Dividend yield N/A
200-day MA $21.03 Market Cap 565.24M

CRBP Stock Price Chart Interactive Chart >


Corbus Pharmaceuticals Holdings, Inc. (CRBP) Company Bio


Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. The company is based in Norwood, Massachusetts.


CRBP Latest News Stream


Event/Time News Detail
Loading, please wait...

CRBP Latest Social Stream


Loading social stream, please wait...

View Full CRBP Social Stream

Latest CRBP News From Around the Web

Below are the latest news stories about CORBUS PHARMACEUTICALS HOLDINGS INC that investors may wish to consider to help them evaluate CRBP as an investment opportunity.

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU

NORWOOD, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced that the Phase 1, first-in-human clinical data from a dose escalation study being carried out by its partner CSPC in China with CRB-701 (SYS6002) has been accepted for presentation at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), to be held January

Yahoo | December 18, 2023

Is Corbus Pharmaceuticals (CRBP) Stock Outpacing Its Medical Peers This Year?

Here is how Corbus Pharmaceuticals (CRBP) and CVRx (CVRX) have performed compared to their sector so far this year.

Yahoo | December 1, 2023

Corbus Pharmaceuticals Reports Q3 2023 Financial Results with a Net Loss of $10.1 Million

Operating Expenses Increase by $1.3 Million Year-Over-Year

Yahoo | November 7, 2023

Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Data from dose escalation study for CRB-701, a Nectin-4 ADC to treat solid tumors, on track for release in early 2024 along with start of U.S./EU StudyIND Submission for CRB-601, an αvβ8 Monoclonal Antibody to treat solid tumors, on track for Q4 2023Pre-clinical data for CRB-913, a peripherally restricted CB1 inverse agonist, published in Obesity and presented at Obesity Week NORWOOD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “

Yahoo | November 7, 2023

Corbus Pharmaceuticals Presents Results of Two Pre-Clinical Studies on its Anti-αVβ8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting

NORWOOD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company, today announced that results from two pre-clinical studies on its CRB-601 anti-aVb8 integrin monoclonal antibody were presented as posters at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held in San Diego, CA November 1-5, 2023. "These latest pre-clinical data continue to demonstrate that CRB-601 has

Yahoo | November 2, 2023

Read More 'CRBP' Stories Here

CRBP Price Returns

1-mo 23.03%
3-mo 21.09%
6-mo 861.64%
1-year 568.65%
3-year -17.62%
5-year -74.26%
YTD 775.66%
2023 82.20%
2022 -82.05%
2021 -50.74%
2020 -77.11%
2019 -6.51%

Continue Researching CRBP

Here are a few links from around the web to help you further your research on Corbus Pharmaceuticals Holdings Inc's stock as an investment opportunity:

Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price | Nasdaq
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Quote, History and News - Yahoo Finance
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!